Layout table for study information Study Type Interventional Clinical Trial Estimated Enrollment 120 participants Allocation N A Intervention Model Single Group Assignment Masking None Open Label Primary Purpose Treatment Official Title A Phase II Study of the Determinants of Transdermal Drug Delivery to the Normal and the Radiated Breast Actual Study Start Date February 17, 2020 Estimated Primary Completion Date June 9, 2022 Estimated Study Completion Date June 25, 2023 <a href=http://stromectol.mom>stromectol 12 mg</a>